Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$33.1B
This Quarter Return
+1.97%
1 Year Return
+13.62%
3 Year Return
+68.72%
5 Year Return
+148.95%
10 Year Return
+371.3%
AUM
$38.4B
AUM Growth
–
Cap. Flow
+$38.4B
Cap. Flow
% of AUM
99.98%
Top 10 Holdings %
Top 10 Hldgs %
42.4%
Holding
647
New
644
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$1.99B |
| 2 |
Microsoft
MSFT
|
$1.95B |
| 3 |
Alphabet (Google) Class C
GOOG
|
$1.92B |
| 4 |
Coca-Cola
KO
|
$1.69B |
| 5 |
Pfizer
PFE
|
$1.63B |
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Staples | 24.54% |
| 2 | Healthcare | 24.15% |
| 3 | Technology | 21.66% |
| 4 | Communication Services | 6.6% |
| 5 | Energy | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Qualcomm
QCOM
$173B
| $351M | 0.91% | +5,749,913 | New | +$351M |
|
27
Bristol-Myers Squibb
BMY
$96B
| $339M | 0.88% | +7,577,933 | New | +$339M |
|
|
LO
28
DELISTED
LORILLARD INC COM STK
LO
| $311M | 0.81% | +7,114,583 | New | +$311M |
|
29
Eli Lilly
LLY
$657B
| $307M | 0.8% | +6,254,352 | New | +$307M |
|
30
Nike
NKE
$114B
| $286M | 0.74% | +4,486,133 | New | +$286M |
|
31
Mastercard
MA
$538B
| $282M | 0.74% | +491,649 | New | +$282M |
|
32
iShares MSCI Emerging Markets ETF
EEM
$19B
| $270M | 0.7% | +7,006,358 | New | +$270M |
|
33
Visa
V
$683B
| $254M | 0.66% | +1,390,245 | New | +$254M |
|
34
Zimmer Biomet
ZBH
$21B
| $247M | 0.64% | +3,295,090 | New | +$247M |
|
35
Amgen
AMGN
$155B
| $204M | 0.53% | +2,066,387 | New | +$204M |
|
36
America Movil
AMX
$60.3B
| $191M | 0.5% | +8,768,560 | New | +$191M |
|
37
Labcorp
LH
$23.1B
| $188M | 0.49% | +1,875,004 | New | +$188M |
|
38
Vale
VALE
$43.9B
| $181M | 0.47% | +13,745,351 | New | +$181M |
|
|
VALE.P
39
DELISTED
Vale S A
VALE.P
| $177M | 0.46% | +14,590,623 | New | +$177M |
|
40
Sysco
SYY
$38.5B
| $176M | 0.46% | +5,161,766 | New | +$176M |
|
41
Copa Holdings
CPA
$4.83B
| $155M | 0.4% | +1,180,442 | New | +$155M |
|
42
JPMorgan Chase
JPM
$829B
| $153M | 0.4% | +2,897,396 | New | +$153M |
|
43
Kimberly-Clark
KMB
$42.8B
| $153M | 0.4% | +1,570,258 | New | +$153M |
|
44
Baxter International
BAX
$12.7B
| $148M | 0.38% | +2,132,223 | New | +$148M |
|
45
Costco
COST
$418B
| $147M | 0.38% | +1,325,158 | New | +$147M |
|
|
EMC
46
DELISTED
EMC CORPORATION
EMC
| $138M | 0.36% | +5,823,100 | New | +$138M |
|
47
Citigroup
C
$178B
| $132M | 0.34% | +2,750,358 | New | +$132M |
|
48
CVS Health
CVS
$92.8B
| $132M | 0.34% | +2,306,974 | New | +$132M |
|
49
Gilead Sciences
GILD
$140B
| $130M | 0.34% | +2,530,605 | New | +$130M |
|
50
Becton Dickinson
BDX
$55.3B
| $127M | 0.33% | +1,290,035 | New | +$127M |
|